Zenith Energy Rated “B+” with Stable Outlook

Zenith Energy

Zenith Energy Ltd., (LON: ZEN; TSX.V: ZEE; OSE: ZENA-ME), the international oil & gas production company, has today announced that Rating-Agentur Expert RA has assigned Zenith a “B+” with Stable Outlook debt issuer credit rating.

RAEX is an independent European Credit Rating Agency with more than 20 years of experience in the rating and analytical industry. It is registered with the European Securities and Markets Authority (“ESMA”) and received ECAI status (External Credit Assessment Institution) in 2015.

The RAEX report can be viewed here: https://raexpert.eu/reports/Press_release_Zenith_Energy_Ltd.18.11.2019.pdf

Andrea Cattaneo, Chief Executive Officer of Zenith Energy, commented:

“The Board is pleased to have received an additional credit rating from an established European credit rating agency.

This rating is expected to help the Company successfully distribute its debt instruments, especially following the recent approval of Zenith’s Prospectus document for the issuance of up to EUR 25 million EMTNs.”

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:

Latest Company News

Gold price recovers above US$4,000 as analysts forecast further gains

Gold recovers above US$4,000 as Standard Chartered maintains its US$4,650 fourth-quarter forecast, supported by central bank purchases and investment...

Cora Gold identifies new mineralised zone at Sanankoro Project

Cora Gold has identified a new 500-metre gold mineralised zone at Sanankoro, with further drilling results pending from several...

Structured Products and CLOs offer alternative routes to investment income

Structured products, private credit and CLOs offer investors alternative income opportunities, with product terms, credit quality and liquidity shaping...

Greencoat UK Wind PLC reports 42% rise in YTD net cash to £267m in Q3 

Greencoat UK Wind generated £267 million in net cash during the first nine months of 2026, an increase of...

Cavendish plc: Showing virtue of flexible cost base

Hardman & Co has maintained a positive view of Cavendish's diversified business model, highlighting its ability to remain profitable...

Cancer research advances bring new treatment options and improve patient outcomes

Advances in cancer research are expanding treatment options, improving early detection and developing more personalised approaches....

    Search